Monographie - Ipratropium bromide - Stabilis 4.0

Utolsó frissítés :
19/11/2024

Muszkarin-antagonista

Ipratropium bromide

aeroszol

Stabilitása gyógyszerészeti készítmények

A keverékek stabilitása

Stabilitást befolyásoló tényezők

Kompatibilitás

Irodalom

pdf

Kémiai szerkezet

aeroszol

Irodalom

aeroszol

Irodalom : Ipratropium bromide

	Type	publikáció
665	Napló	Blondino, FE, Baker M. Stability of Nebulizer Admixtures. Int J Pharm Compound 2005 ; 9, 4: 323-326.
2550	Napló	Roberts GW, Rossi S.O.P. Compatibility of nebulizer solutions Aust J Hosp Pharm 1993 ; 23: 35-37.
2635	Napló	Yamreudeewoh W, Teixeira G, Mayer GE. Stability of levalbuterol in a mixture of levalbuterol and ipratropium nebulizer solution. Hosp Pharm 2008 ; 43, 4: 303-306.
2685	Napló	Jacobson GA, Peterson GM. Stability of ipratropium bromide and salbutamol nebuliser admixtures. Int J Pharm Pract 1995 ; 3: 169-173.
2770	Napló	Krämer I, Schwabe A, Lichtinghagen R, Kamin W. Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol. Pharmazie 2007 ; 62, 10: 760-766.
2774	Napló	McKenzie J.E, Mario Cruz-Rivera M. Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions. Ann Pharmacotherapy 2004 ; 38: 967-972.
2787	Napló	Lee TY, Chen CM, Lee CN, Chaing YC. Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium. Am J Health-Syst Pharm 2005 ; 62, 8: 828-833.
2790	Napló	Kamin W, Schwabe A, Krämer I. Physicochemical compatibility of fluconasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Int J COPD 2007 ; 1, 4: 599-607.
2803	Napló	Bonasia PJ, McVicar WK, Williams B, Ong S. Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium. Respiratory Care 2008 ; 683, 12: 1716-1722.
3019	Napló	Bonasia P, Cook C, Cheng Y et al. Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs. Curr Med Res Opin 2007 ; 23: 2477-2483.
3472	Napló	Krämer I, Schwabe A, Kamin W. Physikalisch-chemische kompatilibität von Mischinhalationslösungen und suspensionen zur simultanen feuchtinhalationstherapie bei Mukoviszidose Patienten. Krankenhauspharmazie 2007 ; 28, 5: 170-178.
3498	Napló	Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions. Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424.

Mentions Légales